Cargando…

PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC

OBJECTIVE: To identify the prevalence of osteoporosis and hypovitaminosis D among patients at the Siriraj Metabolic Bone Disease (MBD) Clinic, and to compare initial vitamin D levels in patients with and without a history of fragility fractures. METHODS: Medical records of patients who attended our...

Descripción completa

Detalles Bibliográficos
Autores principales: UNNANUNTANA, AASIS, CHOTIYARNWONG, POJCHONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ATHA EDITORA 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782860/
https://www.ncbi.nlm.nih.gov/pubmed/29375256
http://dx.doi.org/10.1590/1413-785220172506174133
_version_ 1783295214472921088
author UNNANUNTANA, AASIS
CHOTIYARNWONG, POJCHONG
author_facet UNNANUNTANA, AASIS
CHOTIYARNWONG, POJCHONG
author_sort UNNANUNTANA, AASIS
collection PubMed
description OBJECTIVE: To identify the prevalence of osteoporosis and hypovitaminosis D among patients at the Siriraj Metabolic Bone Disease (MBD) Clinic, and to compare initial vitamin D levels in patients with and without a history of fragility fractures. METHODS: Medical records of patients who attended our MBD clinic between 2012 and 2015 were retrospectively reviewed. Patient baseline demographic, clinical, bone mineral density (BMD), and laboratory data were collected and analyzed. Osteoporosis was diagnosed when patients had a BMD T-score <-2.5 or presented with fragility fractures. RESULTS: There were 761 patients included in this study. Of these, 627 patients (82.4%) were diagnosed with osteoporosis and 508 patients (66.8%) had fragility fractures. Baseline serum 25-hydroxyvitamin D (25(OH)D) levels were available in 685 patients. Of these, 391 patients (57.1%) were diagnosed with hypovitaminosis D. When evaluated only in patients with fragility fractures, the average initial 25(OH)D level was 28.2±11.6 ng/mL, and the prevalence of hypovitaminosis D was 57.6%. CONCLUSION: A high prevalence of osteoporosis and hypovitaminosis D was found among patients at our clinic; two-thirds of patients had a history of fragility fractures, and no difference in initial 25(OH)D levels was seen between patients with and without fragility fractures. Level of Evidence III, Retrospective Study .
format Online
Article
Text
id pubmed-5782860
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher ATHA EDITORA
record_format MEDLINE/PubMed
spelling pubmed-57828602018-01-26 PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC UNNANUNTANA, AASIS CHOTIYARNWONG, POJCHONG Acta Ortop Bras Original Articles OBJECTIVE: To identify the prevalence of osteoporosis and hypovitaminosis D among patients at the Siriraj Metabolic Bone Disease (MBD) Clinic, and to compare initial vitamin D levels in patients with and without a history of fragility fractures. METHODS: Medical records of patients who attended our MBD clinic between 2012 and 2015 were retrospectively reviewed. Patient baseline demographic, clinical, bone mineral density (BMD), and laboratory data were collected and analyzed. Osteoporosis was diagnosed when patients had a BMD T-score <-2.5 or presented with fragility fractures. RESULTS: There were 761 patients included in this study. Of these, 627 patients (82.4%) were diagnosed with osteoporosis and 508 patients (66.8%) had fragility fractures. Baseline serum 25-hydroxyvitamin D (25(OH)D) levels were available in 685 patients. Of these, 391 patients (57.1%) were diagnosed with hypovitaminosis D. When evaluated only in patients with fragility fractures, the average initial 25(OH)D level was 28.2±11.6 ng/mL, and the prevalence of hypovitaminosis D was 57.6%. CONCLUSION: A high prevalence of osteoporosis and hypovitaminosis D was found among patients at our clinic; two-thirds of patients had a history of fragility fractures, and no difference in initial 25(OH)D levels was seen between patients with and without fragility fractures. Level of Evidence III, Retrospective Study . ATHA EDITORA 2017 /pmc/articles/PMC5782860/ /pubmed/29375256 http://dx.doi.org/10.1590/1413-785220172506174133 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Original Articles
UNNANUNTANA, AASIS
CHOTIYARNWONG, POJCHONG
PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
title PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
title_full PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
title_fullStr PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
title_full_unstemmed PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
title_short PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
title_sort prevalence of osteoporosis and hypovitaminosis d at siriraj metabolic bone disease clinic
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782860/
https://www.ncbi.nlm.nih.gov/pubmed/29375256
http://dx.doi.org/10.1590/1413-785220172506174133
work_keys_str_mv AT unnanuntanaaasis prevalenceofosteoporosisandhypovitaminosisdatsirirajmetabolicbonediseaseclinic
AT chotiyarnwongpojchong prevalenceofosteoporosisandhypovitaminosisdatsirirajmetabolicbonediseaseclinic